Efficacy of ciclesonide inhaled once daily versus fluticasone propionate inhaled twice daily in children with asthma (4 to 15 y) (BY9010/M1-205)

Study identifier:BY9010/M1-205

ClinicalTrials.gov identifier:NCT00163410

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A comparative study of inhaled ciclesonide 200 mcg/day vs fluticasone propionate 200 mcg/day in children with asthma

Medical condition

asthma

Phase

Phase 3

Healthy volunteers

No

Study drug

Ciclesonide

Sex

All

Actual Enrollment

500

Study type

Interventional

Age

4 Years - 15 Years

Date

Study Start Date: 01 Apr 2003
Primary Completion Date: 01 Dec 2004
Study Completion Date: 01 Dec 2004

Study design

Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind
Primary Purpose: Treatment

Verification:

Verified 01 Dec 2016 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria